Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BCS | C |
|---|---|---|
| Price | $24.35 | $132.49 |
| Change today | ▲ 0.25% | ▲ 0.42% |
| Market cap | $81.44B | $222.24B |
| Return, 3 months | -7.4% | -7.3% |
| Return, year to date | -2.1% | +15.3% |
| Return, 1 year | +20.2% | +33.1% |
| P/E (TTM) | 9.5 | 14.3 |
| P/B | 0.8 | 1.2 |
| P/E percentile vs own 5y | 81st | 69th |
| Dividend yield | 1.85% | 1.81% |
| Revenue growth (YoY, latest qtr) | +16.0% | +14.3% |
| Net profit growth (YoY) | +30.5% | +49.4% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 22.3% | 18.0% |
| Return on equity | 8.8% | 8.5% |
| Analyst target vs. price | – | +19.0% |
| Analyst buy share | 100% | 79% |
| RSI (14) | 34 | 46 |
| 30-day volatility | 22.4% | 22.5% |
| Max drawdown, 1 year | -26.2% | -14.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.